title: Management of the cardiac transplant recipient: roles of the transplant cardiologist and primary care physician.
abstract: Cardiac transplantation has become an accepted treatment for selected patients with end-stage heart failure. Despite a successful transplant, denervated transplanted hearts respond differently to cardiac drugs than nontransplanted hearts. The treatments for bradycardia, tachycardia, and hypotension are different than for nontransplanted hearts. Despite the improvement in long-term survival, a number of complications may occur posttransplantation. These complications include, allograft rejection, infection, allograft coronary artery disease, and malignancy. Additionally, posttransplant patients may have complications from the immunosuppressive agents cyclosporine, prednisione, and azathioprine. Such complications include drug interactions with commonly prescribed medications, hypertension, hyperlipidemia, osteoporosis, and gastrointestinal complications. The purpose of this article is to discuss the management of the cardiac transplant recipient as it relates to the aforementioned complications. Management of the cardiac transplantation patient by the primary care physician will also be discussed, including indications for consultation by the primary care physician with the transplant center.
authors.affiliation: Division of Cardiology, University of Cincinnati Medical Center, OH 45267-0542, USA.
authors.forename: L E
authors.initials: LE
authors.lastname: Wagoner
mesh_terms: D001919:Bradycardia / Q000188:drug therapy; D002309:Cardiology; D019090:Case Management; D003327:Coronary Disease / Q000175:diagnosis / Q000628:therapy; D005194:Family Practice; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology; D006084:Graft Rejection; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D006973:Hypertension / Q000209:etiology; D007022:Hypotension / Q000628:therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D010024:Osteoporosis / Q000209:etiology; D010819:Physician's Role; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D013610:Tachycardia / Q000188:drug therapy
chemical_list: D007166:Immunosuppressive Agents